| Dr Elvin Antonio Lugo-baez, OD | |
|
200 Ave Fragoso Ste 157, Carolina, PR 00983-3172 | |
| (787) 750-6850 | |
| Not Available |
| Full Name | Dr Elvin Antonio Lugo-baez |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 200 Ave Fragoso Ste 157, Carolina, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093982688 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 402 (Puerto Rico) | Primary |
| Provider Name | Toperbee Corporation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528041167 PECOS PAC ID: 7517287048 Enrollment ID: O20150522000874 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST).
A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.
The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis, if the drug is administered to certain patients with kidney disease.
Oxygen Biotherapeutics, Inc. today reported on the results of two University of Miami Miller School of Medicine studies involving the Company's third-generation perfluorocarbon, Oxycyte® perfluorocarbon emulsion. Both study reports showed that Oxycyte® has a marked neuroprotective effect in a rat model of spinal cord injury.
› Verified 1 days ago
| Provider Name | Luxottica Of America Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114223781 PECOS PAC ID: 2567366180 Enrollment ID: O20170605000893 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST).
A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.
The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis, if the drug is administered to certain patients with kidney disease.
Oxygen Biotherapeutics, Inc. today reported on the results of two University of Miami Miller School of Medicine studies involving the Company's third-generation perfluorocarbon, Oxycyte® perfluorocarbon emulsion. Both study reports showed that Oxycyte® has a marked neuroprotective effect in a rat model of spinal cord injury.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elvin Antonio Lugo-baez, OD Po Box 9386, Caguas, PR 00726-9386 Ph: (787) 653-2275 | Dr Elvin Antonio Lugo-baez, OD 200 Ave Fragoso Ste 157, Carolina, PR 00983-3172 Ph: (787) 750-6850 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST).
A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.
The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis, if the drug is administered to certain patients with kidney disease.
Oxygen Biotherapeutics, Inc. today reported on the results of two University of Miami Miller School of Medicine studies involving the Company's third-generation perfluorocarbon, Oxycyte® perfluorocarbon emulsion. Both study reports showed that Oxycyte® has a marked neuroprotective effect in a rat model of spinal cord injury.
› Verified 1 days ago
Optima Vision 2 Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: Ave. 65 Inanteria Los Colobos Shopping Center, Carr. #3 Km 14 Local 15, Carolina, PR 00987 Phone: 787-368-5905 Fax: 787-769-5900 | |
Dr. Edison Marin, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5829 Ave 65 Infanteria Ste 105, Carolina, PR 00987 Phone: 787-276-3435 Fax: 787-276-4835 | |
Paul Velazquez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Local #203, Carolina, PR 00988 Phone: 787-752-2485 Fax: 787-757-4885 | |
Rafael A Fernandez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Baldorioty De Castro-exp, Carolina, PR 00985 Phone: 787-750-6850 Fax: 787-750-6755 | |
Ms. Ana Nicolle Hernandez Alejandro, OD Optometrist Medicare: Medicare Enrolled Practice Location: Ave. 65 De Infanteria, Km. 12.3, Carolina, PR 00985 Phone: 787-769-2477 | |
Atlantis Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: Ave Monserrate # 97, Numero 28 Villa Carolina, Carolina, PR 00985 Phone: 939-246-1079 Fax: 186-689-9305 |